Bostongene To Showcase Ai-Platform For Drug Development At Aacr
09 Apr 2026 //
PHARMIWEB
BostonGene Showcases AI in Cancer Immunotherapy at PMWC 2026
02 Mar 2026 //
BUSINESSWIRE
Study Confirms BostonGene AI for Precise HER2 Scoring
03 Feb 2026 //
BUSINESSWIRE
BostonGene, Ottimo Pharma Collaborate to Optimize Therapies
08 Jan 2026 //
BUSINESSWIRE
Bostongene, Astrazeneca Partner To Advance Oncology Development
06 Jan 2026 //
BUSINESSWIRE
BostonGene Wins Top Immunology Award from BioTech Breakthrough
16 Dec 2025 //
BUSINESSWIRE
Bostongene Unveils 7 AI-Driven Breast Cancer Breakthroughs
08 Dec 2025 //
BUSINESSWIRE
Bostongene Highlights Ai Impact With Six Abstracts At ASH
25 Nov 2025 //
BUSINESSWIRE
BostonGene, Kyoto University Partner on Precision Drugs Develop
12 Nov 2025 //
BUSINESSWIRE
Bostongene, Sylvester Cancer Center To Present Omnimodal AI
04 Nov 2025 //
BUSINESSWIRE
BostonGene Unveils Omnimodal AI For Cancer & Immune System
28 Oct 2025 //
BUSINESSWIRE
Bostongene Showcases Omnimodal AI In Precision Oncology
23 Oct 2025 //
BUSINESSWIRE
Bostongene Receives Five 2025 Stevie Awards For Tech Excellence
21 Oct 2025 //
PHARMIWEB
Bostongene Highlights Ai Multimodal Analytics At ESMO Congress
14 Oct 2025 //
PHARMIWEB
BostonGene to Present at IASLC 2025 Lung Cancer Conference
26 Aug 2025 //
BUSINESSWIRE
BostonGene wins Frost & Sullivan`s 2025 Tech Leadership Award
22 Jul 2025 //
PR NEWSWIRE
BostonGene, SWOG Team Up for Personalized Cancer Research
08 Jul 2025 //
BUSINESSWIRE
BostonGene to Present AI Drug Tools at Genomics Festival
18 Jun 2025 //
BUSINESSWIRE
BostonGene to Participate at AACR Annual Meeting 2025
21 Apr 2025 //
BUSINESSWIRE
BostonGene Appoints Dr. Ferran Prat as Chief Commercial Officer
08 Apr 2025 //
BUSINESSWIRE
BostonGene Wins Fierce Life Sciences Innovation Award for AI
13 Mar 2025 //
BUSINESSWIRE
BostonGene Wins "Cancer Immunology Solution Of The Year" Award
20 Feb 2025 //
BUSINESSWIRE
BostonGene Explores Therapies, Immune Profiling for GI Cancer
14 Jan 2025 //
BUSINESSWIRE
BostonGene Unveils Transformative Breast Cancer Research at SABCS
10 Dec 2024 //
BUSINESSWIRE
BostonGene to Present 12 Abstracts at ASH Annual Meeting 2024
06 Dec 2024 //
BUSINESSWIRE
BostonGene Wins Five 2024 Pharmaceutical Technology Awards
12 Nov 2024 //
BUSINESSWIRE
BostonGene Participates in EORTC-NCI-AACR Symposium
23 Oct 2024 //
BUSINESSWIRE
Fujita Health And BostonGene Expand Access To Genomic Testing
22 Oct 2024 //
BUSINESSWIRE
BostonGene Drives Value-Based Cancer Care Discussions At AVBCC Summit
16 Oct 2024 //
BUSINESSWIRE
GlobalData Awards BostonGene with Four Clinical Trials Arena Awards
10 Oct 2024 //
BUSINESSWIRE
BostonGene to Present Unique AI-Driven Bioinformatic Solutions
02 Oct 2023 //
BUSINESSWIRE
BostonGene Highlights Approach to IO Research and Precision Medicine at the 6th
20 Jun 2023 //
BUSINESSWIRE

Market Place
Sourcing Support